Cogentis Therapeutics' Incubator/Accelerator Round

Cogentis Therapeutics raised a round of funding on May 21, 2015. Investors include MassChallenge.

Cogentis Therapeutics is developing a drug to treat a family of neurodegenerative disorders, including Alzheimer's Disease, Pick's Disease, and our initial target condition, Frontotemporal Degeneratio…

Articles about Cogentis Therapeutics' Incubator/Accelerator Round: